Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for Array BioPharma Inc. > News item |
Array Biopharma shareholder Kopp Investment reports 5.2% stake
By Lisa Kerner
Charlotte, N.C., Aug. 3 - A group of Array Biopharma, Inc. shareholders led by Kopp Investment Advisors, LLC bought a net 344,556 shares of the company's stock between May 26 and July 24 and priced from $2.92 to $4.78 each, according to a schedule 13D filed on Monday with the Securities and Exchange Commission.
Kopp beneficially owns 2,483,631 shares, or 5.2%, of the Boulder, Colo.-based biopharmaceutical company.
Array develops and commercializes small molecule drugs with a focus on cancer and inflammatory diseases.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.